Patents by Inventor Nicole F. Steinmetz

Nicole F. Steinmetz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250127842
    Abstract: Provided herein are nanoparticles comprising peptides that target checkpoint inhibitors such PD-1 as well as methods for their use. Peptides may be conjugated to nanoparticles such as cowpea mosaic virus or a cowpea chlorotic mottle virus. Nanoparticles provided herein display efficacy against tumors in a mouse model of disseminated and aggressive ovarian cancer.
    Type: Application
    Filed: August 29, 2022
    Publication date: April 24, 2025
    Inventors: Nicole F. Steinmetz, Chao Wang
  • Patent number: 12251410
    Abstract: An agent is described that includes a plant virus particle or VLP conjugate to TRAIL. Associating TRAIL with the plant virus particle or VLP serves to both target cancer cells and induce their apoptosis. The agent can therefore be used for a method of treating cancer in a subject.
    Type: Grant
    Filed: June 13, 2023
    Date of Patent: March 18, 2025
    Assignee: CASE WESTERN RESERVE UNIVERSITY
    Inventor: Nicole F. Steinmetz
  • Patent number: 12239721
    Abstract: A nanoparticle for diagnostic, therapeutic, and/or theranostic applications includes a rod-shaped plant virus like particle (VLP), one or more gadolinium T1 contrast agents conjugated to an interior surface of the VLP, and a layer of polydopamine (PDA) coated over a portion of the exterior surface of the VLP.
    Type: Grant
    Filed: December 15, 2022
    Date of Patent: March 4, 2025
    Assignee: CASE WESTERN RESERVE UNIVERSITY
    Inventors: Nicole F. Steinmetz, He Hu
  • Publication number: 20250049866
    Abstract: An intratumoral immunotherapy for treating cancer in a subject in need includes a therapeutically effective amounts of cowpea mosaic virus (CPMV), CPMV virus-like particles, potato virus X (PVX), and/or PVX virus-like particles formulated for in situ administration to cancer of the subject, wherein the therapeutically effective amount of CPMV, CPMV virus-like particles, PVX, and/or PVX virus-like particles is an amount effective to provide a durable and systemic anticancer response against cancer metastasis and recurrence in the subject, and the CPMV, CPMV virus-like particles, PVX, and/or PVX virus-like particles are not used as a vehicle for drug or antigen delivery.
    Type: Application
    Filed: July 26, 2024
    Publication date: February 13, 2025
    Inventors: Nicole F. Steinmetz, Karin L. Lee
  • Patent number: 12203073
    Abstract: A nanoparticle includes an icosahedral-shaped plant virus particle; an RNAi construct; and one or more endolysosomal release agents, wherein the RNAi construct is noncovalently loaded within the icosahedral-shaped plant virus particle.
    Type: Grant
    Filed: December 21, 2020
    Date of Patent: January 21, 2025
    Assignee: CASE WESTERN RESERVE UNIVERSITY
    Inventor: Nicole F. Steinmetz
  • Publication number: 20250017991
    Abstract: Provided herein is a novel, multimodal in situ vaccination approach to treat cancer by combining ablation with administration of the naturally occurring plant virus or virus-like particle (VLP) nanoparticles such as cowpea mosaic virus (CPMV), a plant virus-based immunoadjuvant.
    Type: Application
    Filed: November 9, 2022
    Publication date: January 16, 2025
    Inventors: Nicole F. Steinmetz, Isabel Newton, Nicholas Webster, Tyler Mandt, Hui Cai, Christine Boone, Mansur Ghani
  • Patent number: 12186279
    Abstract: A nanoparticle construct includes a plurality of plant virus or virus-like particles electrostatically coupled to a plurality of nanoparticles having a different surface charge than the plant virus or virus-like particles. The nanoparticle construct upon delivery to a subject can provide a sustained release of the plant virus or virus-like particles and/or nanoparticles to a cell or tissue of the subject.
    Type: Grant
    Filed: September 6, 2022
    Date of Patent: January 7, 2025
    Assignee: CASE WESTERN RESERVE UNIVERSITY
    Inventors: Nicole F. Steinmetz, Frank Alexander Veliz, Brylee David B. Tiu
  • Publication number: 20250000964
    Abstract: A neoadjuvant for use in treating cancer includes an in situ vaccine and optionally an immune check point therapeutic. The in situ vaccine includes at least one of cowpea mosaic virus or cowpea mosaic virus-like particles.
    Type: Application
    Filed: October 24, 2022
    Publication date: January 2, 2025
    Inventors: Steven Fiering, Hugo Arias-Pulido, Laura Pena, Nicole F. Steinmetz, Gregory W. Ho
  • Patent number: 12156947
    Abstract: A melt processed viral nanoparticle construct for delivery of virus or virus-like particles to a site of interest includes a degradable polymer matrix and a plurality of virus or virus-like particles encapsulated within the degradable polymer matrix. The nanoparticle construct upon administration to the site of interest providing a sustained release of the virus or virus-like particles and/or nanoparticles upon degradation of the polymer matrix.
    Type: Grant
    Filed: May 23, 2023
    Date of Patent: December 3, 2024
    Assignee: CASE WESTERN RESERVE UNIVERSITY
    Inventors: Nicole F. Steinmetz, Jonathan Pokorski
  • Publication number: 20240350422
    Abstract: Proteinaceous nanoparticles can be used to deliver large payloads of active ingredients, which is advantageous in medicine and agriculture. However, the conjugation of hydrophobic ligands to hydrophilic nanocarriers such as plant viral nanoparticles (plant VNPs) can result in aggregation by reducing overall solubility. Provided herein are improved methods for ligand conjugations, as well as the particles prepared by these methods. The disclosed methods promote efficient bioconjugation and prevent the aggregation that accompanies conventional bioconjugation methods, thus improving the stability, homogeneity, and translational potential of plant VNP conjugates in medicine and agriculture.
    Type: Application
    Filed: July 25, 2022
    Publication date: October 24, 2024
    Inventors: Nicole F. Steinmetz, Matthew D. Shin
  • Publication number: 20240285792
    Abstract: Anticancer virus particles are described. Anticancer virus particles are filamentous or rod-shaped plant virus particle containing an anticancer agent within the interior of the virus particle. The anticancer agent can be attached either covalently or non-covalently within the interior of the virus particle. A therapeutically effective amount of an anticancer virus particle can be administered to a subject identified as having cancer to provide a method of cancer treatment.
    Type: Application
    Filed: January 30, 2024
    Publication date: August 29, 2024
    Inventors: Nicole F. Steinmetz, Stephen Lippard, Anna Czapar, Yaorong Zheng
  • Publication number: 20240285793
    Abstract: A method of treating cancer in a subject that includes administering to the cancer a therapeutically effective amount of an anti-cancer virus particle, the virus particle including a rod-shaped plant virus or virus-like particle and mitoxantrone (MTO) or analogs thereof, wherein the MTO is loaded into the interior channel of the rod-shaped plant virus particle.
    Type: Application
    Filed: May 7, 2024
    Publication date: August 29, 2024
    Inventor: Nicole F. Steinmetz
  • Patent number: 12070478
    Abstract: A method of treating cancer in a subject in need thereof includes administering in situ to the cancer a therapeutically effective amount of a virus or virus-like particle.
    Type: Grant
    Filed: February 28, 2023
    Date of Patent: August 27, 2024
    Assignee: CASE WESTERN RESERVE UNIVERSITY
    Inventors: Nicole F. Steinmetz, Karin L. Lee
  • Publication number: 20240261428
    Abstract: A pepino mosaic virus (PepMV) carrier comprising a PepMV particle that has been modified to carry an imaging agent or anticancer agent is described. The PepMV carrier can be used in a method of targeting cancer cells and tissue by administering it to a subject. Cancer tissue targeted by the PepMV carrier can be imaged using an imaging agent, or treated using an anticancer agent.
    Type: Application
    Filed: February 13, 2024
    Publication date: August 8, 2024
    Inventors: Nicole F. Steinmetz, Sourabh Shukla
  • Patent number: 11998594
    Abstract: An anti-cancer virus composition including an icosahedral-shaped plant virus or virus-like particle linked to a HER2 antigen is described. The anti-cancer virus composition can be used for methods of treating or decreasing the risk of developing a HER2-expressing cancer in a subject by administering to a subject in need thereof an effective amount of the anti-cancer virus composition.
    Type: Grant
    Filed: September 30, 2020
    Date of Patent: June 4, 2024
    Assignee: CASE WESTERN RESERVE UNIVERSITY
    Inventors: Nicole F. Steinmetz, Sourabh Shukla
  • Publication number: 20240115635
    Abstract: An agent is described that includes a plant virus particle or VLP conjugate to TRAIL. Associating TRAIL with the plant virus particle or VLP serves to both target cancer cells and induce their apoptosis. The agent can therefore be used for a method of treating cancer in a subject.
    Type: Application
    Filed: June 13, 2023
    Publication date: April 11, 2024
    Inventor: Nicole F. Steinmetz
  • Publication number: 20240108716
    Abstract: Provided are compositions, methods and uses relating to one or more virus or virus-like particle(s), each of which comprises at least one epitope(s) of a pathogen causing the disease or one or more of the cholesterol checkpoint protein(s).
    Type: Application
    Filed: January 7, 2022
    Publication date: April 4, 2024
    Inventors: Nicole F. Steinmetz, Oscar A. Ortega-Rivera, Jonathan K. Pokorski
  • Publication number: 20240093160
    Abstract: A method of targeting cancer tissue in a subject includes administering to the subject a plurality of functionalized Tymovirus virus or virus-like particles loaded with or conjugated to an imaging agent, a therapeutic agent or a targeting agent.
    Type: Application
    Filed: August 29, 2023
    Publication date: March 21, 2024
    Inventors: Nicole F. Steinmetz, Hema Masarapu, He Hu
  • Publication number: 20240091165
    Abstract: A melt processed viral nanoparticle construct for delivery of virus or virus-like particles to a site of interest includes a degradable polymer matrix and a plurality of virus or virus-like particles encapsulated within the degradable polymer matrix. The nanoparticle construct upon administration to the site of interest providing a sustained release of the virus or virus-like particles and/or nanoparticles upon degradation of the polymer matrix.
    Type: Application
    Filed: May 23, 2023
    Publication date: March 21, 2024
    Inventors: Nicole F. Steinmetz, Jonathan Pokorski
  • Publication number: 20240066108
    Abstract: Provided are compositions, methods and uses relating to an adjuvant which comprises, or consists essentially of, or consists of a cowpea mosaic virus (CPMV) particle and its combination with one or more antigens or cells, such as an irradiated cancer cell comprising the one or more antigens.
    Type: Application
    Filed: January 7, 2022
    Publication date: February 29, 2024
    Inventors: Nicole F. Steinmetz, Steven Fiering, Courtney T. Stump